Issue 000 | U.S. Pilot | US

EVGN

Evogene Ltd.

Passing Verified 20-F | 2026-03-26 Filing currency: USD
Margin of Safety 50.4%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
15,631,000USD
Total Liabilities
8,071,000USD
NCAV
7,560,000USD
Cash
12,956,000USD
NCAV per share
needs review
Evidence
10 annual | 13 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one EVGN, then regenerate the site.

Known Unknowns

Only 13 quarterly periods available from Data Vault for this company.

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
20-F
USD
2024-12-31
20-F
USD
2023-12-31
20-F
USD
2022-12-31
20-F
USD
2021-12-31
20-F
USD
2020-12-31
20-F
USD
2019-12-31
20-F
USD
2018-12-31
20-F
USD
2017-12-31
20-F
USD
2016-12-31
20-F
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -14,034,000 -22,210,000 -26,508,000 -26,941,000 -30,953,000 -24,814,000 -21,166,000 -19,989,000 -21,947,000 -21,089,000
Net Income -7,827,000 -18,054,000 -25,954,000 -29,844,000 -30,445,000 -26,206,000 -19,115,000 -20,812,000 -20,838,000 -19,592,000
Cash From Operations n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Accounts Receivable n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets 20,046,000 39,864,000 51,101,000 56,126,000 76,304,000 71,915,000 71,364,000 58,694,000 77,602,000 95,986,000
Total Current Liabilities n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Liabilities 8,071,000 25,026,000 22,416,000 n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding 8,718,193 6,514,589 50,584,588 41,260,439 41,170,168 35,600,088 25,754,297 25,754,297 25,750,547 n/a
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Basic n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 13 quarterly periods available from Data Vault for this company.

Metric
2025-06-30
6-K
USD
2024-12-31
6-K
USD
2024-06-30
6-K
USD
2023-12-31
6-K
USD
2023-06-30
6-K
USD
2022-12-31
6-K
USD
2022-06-30
6-K
USD
2021-12-31
6-K
USD
2021-06-30
6-K
USD
2020-12-31
6-K
USD
2020-06-30
6-K
USD
2019-12-31
6-K
USD
2019-06-30
6-K
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -6,098,000 -22,210,000 -9,404,000 -26,508,000 -14,697,000 -26,941,000 -16,062,000 -30,953,000 -13,705,000 -24,814,000 -12,084,000 -21,166,000 -9,372,000
Net Income -7,671,000 -18,054,000 -9,830,000 -25,954,000 -14,759,000 -29,844,000 -18,860,000 -30,445,000 -14,018,000 -26,206,000 -12,032,000 -19,115,000 -7,895,000
Cash From Operations n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash And Equivalents n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Liabilities 21,551,000 25,026,000 n/a 22,416,000 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding n/a 6,514,589 n/a 50,584,588 n/a 41,260,439 n/a 41,170,168 n/a 35,600,088 n/a 25,754,297 n/a
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Basic n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets n/a derived 2025-06-30 n/a n/a
Total Liabilities 21,551,000USD ifrs-full:Liabilities 2025-06-30 1.00 sec/companyfacts/cik=0001574565/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001574565\companyfacts.json
Cash n/a derived 2025-06-30 n/a n/a
Shares Outstanding n/a n/a 2025-06-30 n/a n/a
NCAV n/a derived 2025-06-30 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share n/a derived 2025-06-30 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 50.4% derived 2025-06-30 n/a gnni_publication_pack | internal_discount

NCAV could not be calculated because one or more inputs are missing.

Source Provenance

Data Source
Data Vault
Data Vault Root
CIK
0001574565
Company ID
n/a
Selected Annual Source
n/a
Selected Quarterly Source
n/a
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
15
Imported At
2026-07-04T23:04:28+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001178913-26-001767
CIK
0001574565
Mary Filing Date
2026-03-26
Filing Currency
USD
Internal Discount
50.4%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-03-26; mary_accession=0001178913-26-001767; mary_cik=0001574565; gnni_supporting_filing_date=2026-03-26; internal_discount=0.504124; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive